Terrie-Anne Cock 35th Lorne Cancer Conference 2023

Terrie-Anne Cock

Terrie-Anne has over 18 years research and development experience, including with multinational pharmaceutical companies GlaxoSmithKline and OSI Pharmaceuticals. Her appointments include leadership roles as Senior Vice President, Therapeutic Research and Development Microba, Director of Biology, Queensland Emory Drug Discovery Initiative, and Director of Translational Research, Benitec Biopharma Limited. She has played key roles in the translation of molecules from research, through clinical trials, and regulatory approvals. This included a diverse range of programs spanning novel, small molecules, biologics, live biotherapeutics, cell-based and gene-based therapies across multiple therapeutic areas. Terrie-Anne undertook a postdoctoral fellowship, at the Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France and has a PhD in Medicine from Garvan Institute and University of New South Wales.

Abstracts this author is presenting: